Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy

Prevention of chemotherapy-induced nausea and vomiting (CINV) is a key component of treatment for patients with cancer. Guidelines are available to assist prescribers in the management of CINV associated with single-day chemotherapy regimens. However, currently there are no clear guidelines for mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Affronti, Mary Lou, Bubalo, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161526/
https://www.ncbi.nlm.nih.gov/pubmed/25228819
http://dx.doi.org/10.2147/CMAR.S68102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161526/
https://www.ncbi.nlm.nih.gov/pubmed/25228819
http://dx.doi.org/10.2147/CMAR.S68102

Ejemplares similares